U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

Showing 2921 - 2930 of 2932 results

Concept
Status:
Possibly Marketed Outside US
Source:
NCT00168727: Phase 4 Lymphoma, Non-Hodgkin
(2003)
Source URL:

Class:
CONCEPT

Concept
Status:
Possibly Marketed Outside US
First approved in 1994
Source:
BLA103411
Source URL:

Class:
CONCEPT

Concept
Status:
First approved in 1993
Source:
BLA103575
Source URL:

Class:
CONCEPT

Concept
Status:
US Unapproved Medicine
First approved in 2007
Source:
Hematogen by Nnodum Pharmaceuticals
Source URL:

Class:
CONCEPT

Showing 2921 - 2930 of 2932 results